Articles On Invion (ASX:IVX)
| Title | Source | Codes | Date |
|---|---|---|---|
|
Top 10 at 11: Nervous wait ahead of China news; but oil stocks, Panther Metals race out the blocks
Good morning, and welcome to Stockhead’s Top 10 at somewhere near 11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: Arcadium soars 47pc as Rio makes move; retailers beg RBA to cut rates before Christmas
ASX rises as banking and tech sectors lead gains Arcadium Lithium surges on potential acquisition by Rio Tinto Retail groups urge Reserve Bank to cut rates ahead of holiday sales The ASX200 index rose by 0.7% on Monday though investors... |
Stockhead | IVX | 1 year ago |
|
September
Health Winners: EZZ and Althea lead upbeat sector sparked by Fed rate cut
Healthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as Fed cuts rates How ASX biotechs performed in the month of September The S&P 500 Health Care Index, a key world benchmark for health... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: Investors rush to mining stocks after China news; while Star crashes 40pc to new low
ASX rises modestly with mining stocks leading gains Fortescue surges nearly 5pc as iron ore prices climb Star Entertainment plunges over 40pc after trading halt lifted The ASX rose modestly by 0.1% on Friday, buoyed by a surge in min... |
Stockhead | IVX | 1 year ago |
|
Top 10 at 11: Medtech, cancer drugs and fintech are this morning’s big winners
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | IVX | 1 year ago |
|
Updates from the Biopharmaceutical Sector: Paradigm Biopharmaceuticals, Actinogen Medical, and Invion
Recent updates highlight significant strides in the biopharmaceutical sector. Paradigm Biopharmaceuticals Ltd has received FDA feedback on its Phase III osteoarthritis study. Actinogen Medical Ltd has secured funding for its Alzheimer’s tri... |
Kalkine Media | IVX | 1 year ago |
|
Closing Bell: ASX choppy as traders sit it out; BPM soars on Mt Gibson gold find
ASX slips after hitting new high ahead of Fed decision Iron ore prices expected to drop below US$80 by 2025 Harvey Norman faces class action lawsuit over warranties The ASX was a bit of a mixed bag today, hitting a new high before pu... |
Stockhead | IVX | 1 year ago |
|
Invion’s INV043 candidate demonstrates positive results in Phase II prostate cancer trial
Life sciences group Invion (ASX: IVX) has announced that its photodynamic technology (PDT) partner RMW Cho Group has completed a Phase II prostate cancer trial using its active pharmaceutical ingredient and lead cancer candidate INV043. The... |
SmallCaps | IVX | 1 year ago |
|
Health Check: Paradigm receives FDA guidance on proposed trial for dodgy knees
Health Check (briefly called Alive and Kicking before we grew tired of the Simple Minds tune running through our noggins) is renowned biotech journo Tim Boreham’s NEW daily wrap covering morning movers and shakers of note in the ASX Healthc... |
Stockhead | IVX | 1 year ago |
|
Alive and Kicking: Prescient Therapeutics chief passes CEO baton after eight years in the job
Alive and Kicking is renowned biotech journo Tim Boreham’s new daily wrap covering morning movers and shakers of note in the ASX Healthcare sector, Monday through Thursday. Prescient Therapeutics chief Steve Yatomi-Clarke resigns to hea... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: ASX falls but lithium stocks rally big on China news; MinRes also jumps 17pc
ASX falls on Wednesday with banks dragging down market Lithium stocks surge on CATL suspension reports; MinRes hits new high Energy stocks struggle as Brent drops below US$70 The ASX was on the back foot on Wednesday, down by 0.3% w... |
Stockhead | IVX | 1 year ago |
|
Top 10 at 11: Titanium sands, defence training and project progress is the news today
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: ASX lifts as CBA, Mac Bank hit record highs; Aruma Resources doubles
ASX closes higher as CBA and Macquarie touch records Lotus Resources finds significant uranium; gold stocks await US CPI data UBS favours ASX banks over miners The ASX bounced back by 0.4% on Tuesday after yesterday’s slump, with the... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: ASX tracks global selloff; Yancoal and GYG amongst new ASX200 entrants
ASX slips as US jobs data fuels Wall Street panic Westpac gets a new CEO Newcomers into the ASX200 index include Guzman u Gomez The ASX stumbled by 0.3% on Monday after the US jobs report fell short on Friday night, causing Wall Str... |
Stockhead | IVX | 1 year ago |
|
Top 10 at 11: Air traffic control training is what’s in the news this morning
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: ASX steady as coal play Coronado sinks 16pc; NextDC rides on data centre boom
ASX up on Thursday, tech stocks rise boosted by NextDC Wodside Energy drops due to downgrade and oil price fall Iron Ore and coal slide, and Coronado sinks on production and cost issues After a rough session on Wednesday, the ASX saw a... |
Stockhead | IVX | 1 year ago |
|
Top 10 at 11: Antimony assays, bad weather and local lockout are today’s top stories
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | IVX | 1 year ago |
|
August Health Winners: LTR Pharma, Control Bionics lead sector at the ‘cusp of an extraordinary era’
ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment The ASX Healthcare Index (AS... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: Star Casino ruled unfit to reclaim licence; Cassius jumps 40pc as AustChina exits lithium deal
ASX 200 up on Friday boosted by strong US GDP and Wall Street gains Star Entertainment gets scathing remarks from regulator Downer EDI and TPG Telecom among the stocks to surge today The ASX closed 0.58% higher on Friday as investors di... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: ASX slides as Qantas’ profit takes big dip; MC Mining triples on Chinese coal deal
The ASX lagged on Thursday after Nvidia’s disappointing Q3 guidance Mineral Resources fell 8pc off a major profit drop Qantas saw a 28pc drop in profit but saw modest share price gains The ASX was sluggish on Thursday, down 0.33%, follo... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: CPI reading shifts rate cut outlook; Tabcorp plunges 15pc while Felix Gold soars
Aussie stocks dropped despite Wall Street edging up ahead of Nvidia’s report Inflation eased to 3.5pc, impacting rate cut predictions Fortescue and Flight Centre reported gains; Woolworths and Tabcorp faced losses Aussie stocks dropped... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: Uranium stocks surge as crunch looms; Actinogen, Kalina lead ASX gains
Aussie shares rose on Fed rate cut hopes Kelsian plunged, while Kalina, Actinogen and Kogan surged Uranium stocks gained on Kazatomprom’s production guidance cut Aussie shares have kicked off the week strongly, buoyed by US Fed Reserve... |
Stockhead | IVX | 1 year ago |
|
Top 10 at 11: Gas powered AI, happy pills, antimony and gold are today’s hot news
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: Windy day for stocks as ANZ, Tabcorp get stung by regulators
ASX ended 10-day winning streak ANZ, Tabcorp dropped after facing regulators Despite a crude price rebound, energy stocks fell The ASX 200 ended its 10-day winning streak, dipping by 0.04% after a weak session on Wall Street overnight.... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: Origin, Cochlear dive on earnings; RBA rate cut looks less likely after jobs report
ASX up as earnings season rolls on; Origin down 10pc, Telstra up 3pc Australia’s unemployment rate edged up to 4.2pc from 4.1pc Iron ore futures dropped below US$94 per ton The ASX edged slightly higher by 0.1% on Thursday, boosted by a... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: Markets still bumpy as ASX drops again; Qantas admits board made mistakes
The ASX dropped, dragged down by Real Estate and Mining stocks Qantas cuts former CEO’s compensation by $9.3m Fears of a US recession are growing, with the Sahm Rule signalling potential trouble A selloff in Real Estate and Mining stock... |
Stockhead | IVX | 1 year ago |
|
July Health Winners: Oncosil, Zelira lead as ASX biotechs power through another strong month
S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July The S&P/ASX 200 Health Care index [XHJ]... |
Stockhead | IVX | 1 year ago |
|
Top 10 at 11: Manganese and a successul cap raise re driving things forward this morning
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | IVX | 1 year ago |
|
Top 10 at 11: Unlikely allies lead out ASX early on Thursday
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | IVX | 1 year ago |
|
Check Up: Europe delivers blow to Alzheimer’s research; and recent ASX health stock winners
The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month In a major blow for... |
Stockhead | IVX | 1 year ago |
|
Top 10 at 11: A bonkers gold MRE and strong quarterlies are making news today
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: ASX ends lower after iron ore majors go full succubi, drain benchmark of joy, life
ASX 200 ends a weak day down but not way down… just -0.23pc All 11 sectors were generally terrible, but 3 ended higher led by Real Estate Small caps led by DGR, ZLD and MSG, with some BIG gains for the day On Tuesday local markets wa... |
Stockhead | IVX | 1 year ago |
|
CLOSING BELL: Iron prices drive a day of quiet gains on the ASX, benchmark up 1.19pc
It has been a quiet enough day in terms of news around the market… and in the absence of salacious headlines to pick apart, and in acknowledgment of the fact that I just want to go home as quickly as possible, because I – like everyone else... |
Stockhead | IVX | 1 year ago |
|
Top 10 at 11: No news is good news for this morning’s early winners
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | IVX | 1 year ago |
|
ASX Health June Winners: Actinogen and Optiscan led a sector in good shape
The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase... |
Stockhead | IVX | 1 year ago |
|
Top 10 at 11: Energy off like a rocket, lithium’s in the news and that’s about it
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: Benchmark trims gains ahead of US inflation tonight and month end portfolio positioning
ASX 200 hit by afternoon profit taking, closing at +0.1pc for the day. 9 of 11 ASX sectors were higher, so… two of them weren’t. Small cap gains led by East33, and the world is their oyster. Local markets trimmed most of the early mor... |
Stockhead | IVX | 1 year ago |
|
Top 10 at 11: Takeover talks and a mega gold upgrade are driving the market today
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: ASX adds 1.4pc as KFC-owner kills it on post-taco Tuesday
ASX closes almost 1.4pc higher Broad-based gains Top small cap performers led by Vonex The local benchmark index has lifted on Tuesday, with broad-based gains driving all 11 sectors into the green. The S&P/ASX200 closed 105.10 poi... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: Shares drop again on the eve of Fed decision; Adbri says goodbye to ASX after 62 years
ASX down 0.5pc, Energy sector up due mainly to Woodside’s upgrade. CRH to acquire Adbri, ending Adbri’s 62-year ASX presence China’s data CPI keeps increasing, new data shows The ASX continued yesterday’s decline, down another -0.5% tod... |
Stockhead | IVX | 1 year ago |
|
ASX Health Winners in May: LTR Pharma leads, and why hopes are high for biotech stocks this year
S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month The S&P/ASX 200 Health Care [XHJ] closed flattish for the month o... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: ASX takes a 1pc hit as inflation spooks; IMF bullish on China
Aussie stocks fell 1pc on rising inflation ASX sectors mostly down; IAG hit by class action lawsuit Asian markets dropped; IMF ups China’s growth forecast to 5pc Aussie stocks fell by 1% on Wednesday, hitting their lowest point in three... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: ASX dips, goldies lead, and Forrestania jumps 140pc on iron ore play
ASX 200 dips amid Wall Street closure for Memorial Day Commodities bounce back; gold stocks rise, uranium falls Forrestania jumps on iron ore play The ASX 200 edged down -0.2% on Tuesday as local traders navigated a directionless marke... |
Stockhead | IVX | 1 year ago |
|
Top 10 at 10: Banana recycler slides into big contract win
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | IVX | 1 year ago |
|
Check Up: Alzheimer’s is ‘preventable’, so here’s what you must do; and recent ASX biotech winners
Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month The phrase ‘you are what you eat’ was coined almost a c... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: Copper stocks are rolling, but not the ASX ahead of Federal Budget and US inflation
ASX retreats on Tuesday ahead of Fed Budget and US PPI/CPI Copper stocks up after the metal hit highest level since 2022 GUD jumps 11pc after strong FY24 update The ASX dipped by -0.4% on Tuesday ahead of the Federal Budget and a key PP... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: ASX fleeced as retail stocks plunge; Alliance Nickel soars on great big grant
ASX losses accelerate after sluggish retail sector updates Baby Bunting, Temple & Webster, JB Hi-fi all under pressure on soft sales Alliance Nickel soars on fat federal grant After opening modestly higher this morning, the ASX qui... |
Stockhead | IVX | 1 year ago |
|
Closing Bell: ASX rallies hard as RBA holds rates; Bonza drama continues with court ruling
ASX rallies, with all sectors rallying on Tuesday The RBA holds rate, but keeps door open for more rate hikes Update on Bonza Airlines’ ongoing drama The Aussie stock market rallied hard on Tuesday, up over +1%, as the RBA decided to ho... |
Stockhead | IVX | 1 year ago |
|
ASX Health Winners April: Mesoblast leads; and why the Health sector is just built different
ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month The S&P/ASX 200 Health Care [XHJ] had a soft month in April... |
Stockhead | IVX | 1 year ago |
|
Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners
There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month Scientists have made a significant b... |
Stockhead | IVX | 1 year ago |